Board of Trustees of The Leland Stanford Junior University - ALX ONCOLOGY HLDGS INC ownership

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 95 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.

Quarter-by-quarter ownership
Board of Trustees of The Leland Stanford Junior University ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q2 2021$14,216,000
-62.8%
259,982
-49.9%
1.33%
-60.7%
Q1 2021$38,258,000
-69.3%
518,822
-64.1%
3.38%
-61.5%
Q4 2020$124,718,000
+128.4%
1,446,8540.0%8.79%
-58.2%
Q3 2020$54,604,0001,446,85421.04%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q1 2021
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$715,272,00067.97%
Logos Global Management LP 3,156,981$232,796,00022.72%
Vivo Capital, LLC 4,220,048$311,186,00010.94%
Foresite Capital Management IV, LLC 785,945$57,956,0006.94%
Foresite Capital Management V, LLC 320,000$23,597,0006.94%
Board of Trustees of The Leland Stanford Junior University 518,822$38,258,0003.38%
Cormorant Asset Management, LP 881,770$65,022,0001.45%
Redmile Group, LLC 978,600$72,162,0001.02%
SPHERA FUNDS MANAGEMENT LTD. 130,351$9,612,0000.74%
Artal Group S.A. 525,000$38,714,0000.68%
View complete list of ALX ONCOLOGY HLDGS INC shareholders